Crestline Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-33,893
Closed -$4.12M 557
2024
Q4
$4.12M Buy
+33,893
New +$4.12M 0.14% 166
2018
Q3
Sell
-14,160
Closed -$1.87M 227
2018
Q2
$1.87M Buy
+14,160
New +$1.87M 0.2% 149
2017
Q3
Sell
-61,410
Closed -$2.07M 167
2017
Q2
$2.07M Buy
61,410
+28,810
+88% +$971K 0.28% 37
2017
Q1
$965K Buy
+32,600
New +$965K 0.18% 56